185 related articles for article (PubMed ID: 23469620)
1. OX40-OX40L expression in idiopathic inflammatory myopathies.
Papadopoulos C; Terzis G; Papadimas GK; Manta P
Anal Quant Cytopathol Histpathol; 2013 Feb; 35(1):17-26. PubMed ID: 23469620
[TBL] [Abstract][Full Text] [Related]
2. Requirements for the functional expression of OX40 ligand on human activated CD4+ and CD8+ T cells.
Kondo K; Okuma K; Tanaka R; Zhang LF; Kodama A; Takahashi Y; Yamamoto N; Ansari AA; Tanaka Y
Hum Immunol; 2007 Jul; 68(7):563-71. PubMed ID: 17584577
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells.
Arahata K; Engel AG
Ann Neurol; 1984 Aug; 16(2):193-208. PubMed ID: 6383191
[TBL] [Abstract][Full Text] [Related]
4. Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies.
Grundtman C; Salomonsson S; Dorph C; Bruton J; Andersson U; Lundberg IE
Arthritis Rheum; 2007 Feb; 56(2):674-87. PubMed ID: 17265504
[TBL] [Abstract][Full Text] [Related]
5. [The role of OX40 in CD4+ T cells cytokines production in ulcerative colitis].
Wang XD; Wu TY
Zhonghua Nei Ke Za Zhi; 2008 Jan; 47(1):15-8. PubMed ID: 18346319
[TBL] [Abstract][Full Text] [Related]
6. The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy.
Haslbeck KM; Friess U; Schleicher ED; Bierhaus A; Nawroth PP; Kirchner A; Pauli E; Neundörfer B; Heuss D
Acta Neuropathol; 2005 Sep; 110(3):247-54. PubMed ID: 15986224
[TBL] [Abstract][Full Text] [Related]
7. [Expressions and clinical significance of OX40 and OX40L in peripheral blood of patients with primary Sjogren's syndrome].
Zhu R; Jiang J; Wang T; Xu T; Wu M; Liu C; Zhang X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Aug; 29(8):862-5. PubMed ID: 23948416
[TBL] [Abstract][Full Text] [Related]
8. A recombinant vesicular stomatitis virus encoding HIV-1 receptors and human OX40 ligand efficiently eliminates HIV-1-infected CD4-positive T cells expressing OX40.
Tsuruno C; Okuma K; Takahashi Y; Tanaka R; Tanaka Y; Takahama Y; Hamaguchi Y; Hamaguchi I; Yamaguchi K
Hum Immunol; 2011 Apr; 72(4):295-304. PubMed ID: 21262309
[TBL] [Abstract][Full Text] [Related]
9. OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy.
Shibahara I; Saito R; Zhang R; Chonan M; Shoji T; Kanamori M; Sonoda Y; Kumabe T; Kanehira M; Kikuchi T; So T; Watanabe T; Takahashi H; Iwabuchi E; Tanaka Y; Shibahara Y; Sasano H; Ishii N; Tominaga T
Mol Cancer; 2015 Feb; 14():41. PubMed ID: 25744203
[TBL] [Abstract][Full Text] [Related]
10. Negative regulation of IL-17 production by OX40/OX40L interaction.
Li J; Li L; Shang X; Benson J; Merle Elloso M; Schantz A; Bracht M; Orlovsky Y; Sweet R
Cell Immunol; 2008; 253(1-2):31-7. PubMed ID: 18501882
[TBL] [Abstract][Full Text] [Related]
11. OX40 ligand and OX40 are increased in atopic dermatitis lesions but do not correlate with clinical severity.
Ilves T; Harvima IT
J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):e197-205. PubMed ID: 22646697
[TBL] [Abstract][Full Text] [Related]
12. OX40L/OX40 axis impairs follicular and natural Treg function in human SLE.
Jacquemin C; Augusto JF; Scherlinger M; Gensous N; Forcade E; Douchet I; Levionnois E; Richez C; Lazaro E; Duffau P; Truchetet ME; Seneschal J; Couzi L; Pellegrin JL; Viallard JF; Schaeverbeke T; Pascual V; Contin-Bordes C; Blanco P
JCI Insight; 2018 Dec; 3(24):. PubMed ID: 30568041
[TBL] [Abstract][Full Text] [Related]
13. [Expression of adhesion molecules in idiopathic inflammatory myopathies. Immunohistochemical study of 17 cases].
Liprandi A; Figarella-Branger D; Daniel L; Lepidi H; Bartoli C; Pellissier JF
Ann Pathol; 1999 Mar; 19(1):12-8. PubMed ID: 10320905
[TBL] [Abstract][Full Text] [Related]
14. OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response.
Jacquemin C; Schmitt N; Contin-Bordes C; Liu Y; Narayanan P; Seneschal J; Maurouard T; Dougall D; Davizon ES; Dumortier H; Douchet I; Raffray L; Richez C; Lazaro E; Duffau P; Truchetet ME; Khoryati L; Mercié P; Couzi L; Merville P; Schaeverbeke T; Viallard JF; Pellegrin JL; Moreau JF; Muller S; Zurawski S; Coffman RL; Pascual V; Ueno H; Blanco P
Immunity; 2015 Jun; 42(6):1159-70. PubMed ID: 26070486
[TBL] [Abstract][Full Text] [Related]
15. Costimulatory molecule OX40/OX40L expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
Xie F; Wang Q; Chen Y; Gu Y; Mao H; Zeng W; Zhang X
Pathol Res Pract; 2010 Nov; 206(11):735-9. PubMed ID: 20634005
[TBL] [Abstract][Full Text] [Related]
16. Leucocyte/endothelial cell adhesion receptors in muscle biopsies from patients with idiopathic inflammatory myopathies (IIM).
Cid MC; Grau JM; Casademont J; Tobías E; Picazo A; Coll-Vinent B; Esparza J; Pedrol E; Urbano-Márquez A
Clin Exp Immunol; 1996 Jun; 104(3):467-73. PubMed ID: 9099932
[TBL] [Abstract][Full Text] [Related]
17. Localization of the alpha-chemokine SDF-1 and its receptor CXCR4 in idiopathic inflammatory myopathies.
De Paepe B; Schröder JM; Martin JJ; Racz GZ; De Bleecker JL
Neuromuscul Disord; 2004 Apr; 14(4):265-73. PubMed ID: 15019705
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cells and the immunopathogenesis of idiopathic inflammatory myopathies.
de Padilla CM; Reed AM
Curr Opin Rheumatol; 2008 Nov; 20(6):669-74. PubMed ID: 18946326
[TBL] [Abstract][Full Text] [Related]
19. The Immune Checkpoint Modulator OX40 and Its Ligand OX40L in NK-Cell Immunosurveillance and Acute Myeloid Leukemia.
Nuebling T; Schumacher CE; Hofmann M; Hagelstein I; Schmiedel BJ; Maurer S; Federmann B; Rothfelder K; Roerden M; Dörfel D; Schneider P; Jung G; Salih HR
Cancer Immunol Res; 2018 Feb; 6(2):209-221. PubMed ID: 29321210
[TBL] [Abstract][Full Text] [Related]
20. Detection and characterization of OX40 ligand expression in human airway smooth muscle cells: a possible role in asthma?
Burgess JK; Carlin S; Pack RA; Arndt GM; Au WW; Johnson PR; Black JL; Hunt NH
J Allergy Clin Immunol; 2004 Apr; 113(4):683-9. PubMed ID: 15100674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]